Teva's first quarter profit misses estimates
Teva Pharmaceutical Industries today reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its branded drugs to treat migraines and Huntington's disease rose.
Business
• 08 May 24
